A4240 Ratio | List of Frontiers open access articles

Original Research

Published on 28 May 2018

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale

in Alzheimer's Disease and Related Dementias

Sylvain Lehmann
Constance Delaby
Guilaine Boursier
Cindy Catteau
Nelly Ginestet
Laurent Tiers
Aleksandra Maceski
Sophie Navucet
Claire Paquet
Julien Dumurgier

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2018.00138

18,094 views
81 citations

Original Research

Published on 25 Mar 2024

Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment

in Dementia and Neurodegenerative Diseases

Darren M. Weber
Steven W. Taylor
Robert J. Lagier
Jueun C. Kim
Scott M. Goldman
Nigel J. Clarke
David E. Vaillancourt
Ranjan Duara
Karen N. McFarland
Wei-en Wang

Frontiers in Neurology

doi 10.3389/fneur.2024.1364658

13,129 views
25 citations

Original Research

Published on 23 Mar 2022

Non-linear Character of Plasma Amyloid Beta Over the Course of Cognitive Decline in Alzheimer’s Continuum

in Alzheimer's Disease and Related Dementias

Feng-Feng Pan
Qi Huang
Ying Wang
Yi-Fan Wang
Yi-Hui Guan
Fang Xie
Qi-Hao Guo

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.832700

5,347 views
21 citations

Original Research

Accepted on 28 Apr 2026

Inner Retinal Layer Thickness Reflects Plasma Biomarkers in Preclinical Alzheimer's Disease

in Ophthalmology

Jane Chan
Ziyuan Wang
Emily Xu
Ibrahim Abboud
Aya Alhasany
Sophia Xu
Xiaomeng Wu
Natalie Astraea
Fei Jiang
Zhihong Jewel Hu

Frontiers in Medicine

183 views

Original Research

Published on 23 Jun 2025

α-klotho as a biomarker of amyloid β levels in the cerebrospinal fluid

in Alzheimer's Disease and Related Dementias

Jacob Raber
Alexandra Pederson
Emily Bunnell
Nora Mattek
Nora E. Gray
Steven G. Kohama
Alison R. Weiss
Joseph F. Quinn
Henryk F. Urbanski

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1599402

2,856 views
2 citations

Original Research

Published on 04 Sep 2023

Adiponectin and resistin modulate the progression of Alzheimer´s disease in a metabolic syndrome model

in Neuroendocrine Science

Pedro Cisternas
Camila Gherardelli
Joel Gutierrez
Paulina Salazar
Carolina Mendez-Orellana
G. William Wong
Nibaldo C. Inestrosa

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1237796

8,816 views
20 citations

Original Research

Published on 30 May 2025

Blood essential trace elements and Alzheimer’s disease biomarkers in midlife

in Alzheimer's Disease and Related Dementias

Xin Wang
Kelly M. Bakulski
Carrie A. Karvonen-Gutierrez
Sung Kyun Park
David Morgan
Brian P. Jackson
Roger L. Albin
Henry L. Paulson

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1539749

3,335 views
4 citations

Original Research

Published on 14 Mar 2023

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity

in Alzheimer's Disease and Related Dementias

Min Young Chun
Hyemin Jang
Hee Jin Kim
Jun Pyo Kim
John Gallacher
José Antonio Allué
Leticia Sarasa
Sergio Castillo
María Pascual-Lucas
Duk L. Na

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1126799

3,823 views
6 citations

Original Research

Published on 08 Dec 2022

Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve

in Cognition

Luca Kleineidam
Steffen Wolfsgruber
Anne-Sophie Weyrauch
Linn E. Zulka
Simon Forstmeier
Sandra Roeske
Hendrik van den Bussche
Hanna Kaduszkiewicz
Birgitt Wiese
Siegfried Weyerer

Frontiers in Psychology

doi 10.3389/fpsyg.2022.957308

8,863 views
24 citations

Original Research

Published on 11 Mar 2016

Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD

in Alzheimer's Disease and Related Dementias

Nuomin Li
Kefu Liu
Yunjie Qiu
Zehui Ren
Rongji Dai
Yulin Deng
Hong Qing

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2016.00051

11,208 views
51 citations

Original Research

Published on 04 Jul 2024

ACOT7, a candidate and novel serum biomarker of Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Jintao Wang
Yong Feng
Yingni Sun

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1345668

4,647 views
2 citations

Articles

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale

Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer’s disease assessment

Non-linear Character of Plasma Amyloid Beta Over the Course of Cognitive Decline in Alzheimer’s Continuum

Inner Retinal Layer Thickness Reflects Plasma Biomarkers in Preclinical Alzheimer's Disease

α-klotho as a biomarker of amyloid β levels in the cerebrospinal fluid

Adiponectin and resistin modulate the progression of Alzheimer´s disease in a metabolic syndrome model

Blood essential trace elements and Alzheimer’s disease biomarkers in midlife

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity

Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve

Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD

ACOT7, a candidate and novel serum biomarker of Alzheimer’s disease